CDK9-IN-49
CDK9-IN-49 is a CDK9 inhibitor with an IC50 of 7.32 nM. CDK9-IN-49 inhibits the proliferation of various cancer cells. CDK9-IN-49 can be used in the research of cancers such as acute myeloid leukemia and prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2987897-39-0
- Formule: C23H24FN5O2S
- Masse moléculaire:453.53
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
CDK9 7.32 nM (IC50) |
CDK9-IN-49 (Example 27) (0.00000256-1 μM, 3 days) potently inhibits the viability of MOLM-13 acute myeloid leukemia cells, LNCaP prostate cancer cells, and MV-4-11 acute myeloid leukemia cells, with IC50 values of 0.428, 0.72, and 1.29 nM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MOLM-13, LNCaP, MV-4-11 cell
-
Concentration:0.00000256-1μM, starting with 1 μM, a 5-fold serial dilution was performed to obtain 9 concentrations
-
Incubation Time:3 days
-
Result:Inhibited MOLM-13 cell viability with an IC50 of 0.428 nM.
Inhibited LNCaP cell viability with an IC50 of 0.72 nM.
Inhibited MV-4-11 cell viability with an IC50 of 1.29 nM.
Chemical Information
-
CAS No. 2987897-39-0
-
Masse moléculaire 453.53
-
Formule C23H24FN5O2S
-
SMILES
CN1C(C(C)C)=C2C=C(C3=C(F)C=NC(NC4=CC(CS(C)(=O)=O)=CC=N4)=C3)C=CC2=N1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)